Oregon legislation · 2026 Legislative Measures
Oregon HB4110: Relating to ibogaine; prescribing an effective date.
Status: Failed, March 6, 2026
Digest: The Act says a doctor can give a patient ibogaine if the ibogaine will help to treat the patient's disorder. (Flesch Readability Score: 63.8). Allows an attending physician to provide ibogaine to a patient for the patient's consumption to treat certain disorders. Defines "attending physician" and "ibogaine." Exempts ibogaine, when obtained, provided and consumed as specified, from the definition of "controlled substance." Takes effect on the 91st day following adjournment sine die.
What the bill says
A bill FOR AN ACT Relating to ibogaine; creating new provisions; amending ORS 475.005; and prescribing an effective date.
From the introduced text, January 28, 2026:
A BILL FOR AN ACT Relating to ibogaine; creating new provisions; amending ORS 475.005; and prescribing an effective date. Be It Enacted by the People of the State of Oregon: SECTION 1. (1) As used in this section: (a) "Attending physician" means the physician who has primary responsibility for the care of a patient. (b) "Ibogaine" means a naturally occurring indole alkaloid extracted from the root bark of the Tabernanthe iboga shrub. (c) "Physician" means a doctor of medicine or doctor of osteopathy licensed under ORS chapter 677. (2)(a) An attending physician of a patient who meets the criteria listed in paragraph (b) of this subsection may provide ibogaine to the patient for the patient's consumption to treat the patient's diagnosed post-traumatic stress disorder, major depressive disorder, anxiety disorder or substance use disorder, if in the attending physician's judgment, the patient's disorder may benefit from the consumption of ibogaine. (b) In order to receive ibogaine under paragraph (a) of this subsection, a patient and (B) In the opinion of the patient's attending physician, be able to make and communicate health care decisions to a health care provider, either directly or through individuals familiar with the patient's manner of communicating. (3) The consumption of ibogaine must occur in a controlled setting: (a) Where a health care provider who is experienced in …
Sponsors
- Alek Skarlatos (R, 4) · primary sponsor
- David Smith (R, 1) · primary sponsor
- Robert Nosse (D, 42) · primary sponsor
- Court Boice (R, 1)
- Darcey Edwards (R, 31)
- Darin Harbick (R, 12)
- Rick Lewis (R, 18)
Latest actions
- : In committee upon adjournment.
- : Public Hearing held.
- : Referred to Behavioral Health.
- : First reading. Referred to Speaker's desk.
Common questions
- What is HB4110?
- HB4110 is a bill in the Oregon Legislature (2026 Legislative Measures): Relating to ibogaine; prescribing an effective date.
- What does HB4110 do?
- In its own words: A bill FOR AN ACT Relating to ibogaine; creating new provisions; amending ORS 475.005; and prescribing an effective date.
- What is the status of HB4110?
- Failed as of March 6, 2026. Latest action: In committee upon adjournment. (March 6, 2026).
- Who sponsored HB4110?
- Alek Skarlatos (R, 4), with 6 co-sponsors.
- Where is the official record for HB4110?
- On the Oregon Legislature website: https://olis.oregonlegislature.gov/liz/2026R1/Measures/Overview/4110
Source: official Oregon record. Tracked by Delilah, AI for legislation across all 50 states and Congress.